[1]
PEREIRA, E.S. et al. 2026. Assessment of the Economic Impact of Warfarin Substitution with Rivaroxaban. Journal of Hospital Pharmacy and Health Services. 17, 1 (Apr. 2026), e1311. DOI:https://doi.org/10.30968/jhphs.2026.171.1311.